Navigator Global Investments acquired a 23.5% strategic stake in 1315 Capital for approximately $70.5m, expanding its presence in the healthcare-focused private equity sector. 

The transaction strengthens Navigator’s portfolio while supporting 1315 Capital’s continued growth.

1315 Capital, which manages over $1bn in assets, specialises in growth equity and buyouts within commercial-stage pharmaceutical outsourcing, medical technology, healthcare services, and wellness companies. The firm targets scalable businesses that drive innovation and impact across the healthcare sector.

Navigator CEO Stephen Darke described the investment as a pivotal move in the firm’s strategy to partner with leading alternative asset managers. “This is a compelling opportunity to collaborate with a proven and growing specialist private equity manager. It broadens our exposure in private markets and does so in a sector with exciting and scalable opportunities,” he said.

1315 Capital founder Adele C. Oliva welcomed the partnership, noting that Navigator’s expertise in operational best practices, talent acquisition, and client expansion would strengthen the firm’s market position.

The investment will not affect 1315 Capital’s management structure or investment decision-making processes. Navigator will fund the deal using its existing resources and has appointed Fried, Frank, Harris, Shriver & Jacobson as legal counsel. 1315 Capital has enlisted Ardea Partners as financial advisor and Ropes & Gray as legal counsel.

With this acquisition, Navigator continues to expand its footprint in private equity, reinforcing its commitment to diversifying investments across high-growth alternative asset classes.